Daniel Tran, PharmD
Hematology/Oncology Product Marketing Manager
Evidence-Based Launch Strategy
Oncology Product Marketing & Launch Strategy
Greater Seattle Area, WA
Clinical Science Applied to Commercial Strategy
Specialty oncology launches fail when commercial strategy disconnects from clinical evidence. I bring a PharmD's training to product marketing — grounding competitive positioning, market access planning, and HCP engagement in the science that prescribers actually care about.
“The best commercial strategies start with the clinical data. Everything else — positioning, access, messaging — follows from whether you understood the science correctly.”
Experience Highlights
- Pfizer Oncology — ADCETRISLed Seagen-to-Pfizer portfolio integration ($2M budget, 600+ assets, $400K savings). Managed ~$10M OPEX brand budget. Repositioned SEM strategy for 38% SOV increase with 25% budget optimization.
- PrecisePK — Clinical Decision SupportLed strategic roadmap for Epic/Cerner EHR integration. Navigated VA federal procurement for VISN 22 adoption. Directed scientific white papers on Bayesian dosing.
- Competitive Intelligence & Market AccessDirected $0.5M CI strategy synthesizing FDA/ODAC signals. Takeda Global Alliance ADC biosimilar analysis. Led AMO/EMPOWER platform launch.
- Education & TechnicalUC San Diego Skaggs School of Pharmacy (PharmD). Veeva CRM/Vault, GA4, Tableau, Bayesian Statistics, Next.js, AI-Assisted Development (Claude, Gemini).
Clinical Strategy Simulations
Strategic Analysis: Comparative Launch Dynamics in Desmoid Tumors
Second-entrant launch strategy for varegacestat vs. nirogacestat (Ogsiveo) — cross-trial comparison with placebo arm vulnerability assessment, revenue forecasting, risk-weighted positioning architecture, and digital execution framework.
Launch Readiness Scorecard: Risk-Weighted Assessment for Lower-Risk MDS
Interactive 7-dimension framework with failure-benchmarked weights, 24 diagnostic questions, and a fully worked MDS case study analyzing an oral erythropoiesis modifier vs. Reblozyl (luspatercept, BMS).
Clinical Case Studies / Portfolio
RNCalc: Clinical Decision Support for Nursing
A clinical decision-support suite for oncology nursing — 28 calculators, 17 charting templates, and 7 brain sheet specialties bridging EHR data and bedside clinical calculations.
Competitive Intelligence & Strategic Signaling
Monitoring FDA, ODAC, and biosimilar signals to inform defensive positioning for oncology brands.
Civis Health: Financial Assistance Within Reach
A free, privacy-first tool automating hospital financial assistance eligibility and PDF application generation for underserved patients.
Bayesian Vancomycin PK Calculator
Advanced pharmacokinetic calculator with Bayesian MAP estimation, 5 population PK models, AUC-guided dosing, and interactive concentration-time profiling.
ML-Driven Predictive Dosing
Gradient boosting model for vancomycin AUC prediction with interactive feature importance, training visualization, and personalized medicine roadmap.
ML-Based KOL/HCP Segmentation
K-means clustering for pre-launch HCP targeting in rare oncology, using synthetic claims data, publication signals, and conference attendance to build actionable prescriber segments.
Monte Carlo Budget Impact Model
Probabilistic payer budget simulation for rare oncology market entry, with tornado sensitivity analysis, scenario modeling, and PMPM impact projections.
CI Command Center
Competitive intelligence command center for cholangiocarcinoma — integrating ClinicalTrials.gov pipeline data, PubMed KOL analytics, and sponsor tracking into a unified strategic dashboard.
KOL Influence Network
Graph analytics mapping opinion leader influence in IDH-mutant cholangiocarcinoma, with PageRank centrality, Louvain community detection, and interactive force-directed visualization.
Survival Analysis Simulator
Kaplan-Meier survival curves, Cox proportional hazards, and subgroup forest plots for a synthetic uveal melanoma trial modeled after IMCgp100-202.
Bayesian A/B Testing Engine
Thompson sampling-based adaptive allocation for IgA nephropathy HCP marketing campaigns, with posterior visualization and expected loss decision analysis.
ADCETRIS: Omnichannel Resilience
[Coming Soon] Digital strategy and cross-portfolio clinical library management.
About
I'm a PharmD (UC San Diego, Skaggs School of Pharmacy) who has spent a career at the intersection of clinical science and commercial execution. From hospital pharmacy to HealthTech product management at PrecisePK to Pfizer Oncology brand marketing, my arc has always been about closing the gap between what clinicians know and what technology can deliver.
Today, I apply that same translational mindset to oncology product marketing — managing multi-million dollar brand budgets, driving commercial strategy, and applying technical depth to problems that typically sit between medical affairs, market access, and brand marketing.
Education
Doctor of Pharmacy (PharmD)
UC San Diego — Skaggs School of Pharmacy
Technical
Veeva CRM/Vault, GA4, Tableau, Bayesian Statistics, IQVIA, Next.js, AI-Assisted Development (Claude, Gemini)